Full Title
A Phase 3, Multicenter, Prospective Open-Label Study to Evaluate the Diagnostic Performance of [18F]FAPI-74 PET/CT for the Detection of Metastatic Disease in Adults with Pancreatic Ductal Adenocarcinoma (FAPI-PRO) (WCG IoR)Purpose
To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.
Contact
For more information or to see if you can join this study, please call Dr. Ali Aria Razmaria’s office at 212-639-7373.
Protocol
26-089
Phase
Phase III (phase 3)
Investigator
ClinicalTrials.gov ID
NCT07217717